Eli Lilly and Company (LLY): A Bull Case Theory 

We came across a bullish thesis on Eli Lilly and Company on Pebble Bites’s Substack by Christina Gan. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company's share was trading at $1,075.47 as of November 28th. LLY’s trailing and forward P/E were 52.69 and 33.90, respectively according to Yahoo Finance.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. LLY presents a compelling BUY opportunity as a global leader addressing major health issues, including...